Inactive Instrument

News Kiadis Pharma N.V.

Equities

KDS

NL0011323407

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sanofi : Delays Privatization of Kiadis on Pending Mandatory Buy-Out	21-07-15	MT
Certain Ordinary Shares of Kiadis Pharma N.V. are subject to a Lock-Up Agreement Ending on 31-MAY-2021.	21-05-30	CI
Kiadis Pharma N.V.(ENXTAM:KDS) dropped from Next Biotech Index	21-05-24	CI
Kiadis Pharma N : - Notice of Annual General Meeting of Shareholders	21-05-14	AQ
Kiadis Pharma N : AGM QA Protocol	21-05-13	PU
Kiadis Pharma N : AGM Agenda	21-05-13	PU
Kiadis Pharma N : AGM Proxy	21-05-13	PU
Sanofi : to Delist Kiadis in Amsterdam, Brussels on May 25	21-04-29	MT
Final results of the Offer for Kiadis: 97.39% of Kiadis Shares in total committed under the Offer	21-04-29	AQ
Sanofi : to Delist Kiadis from Euronext on May 25	21-04-26	MT
Sanofi : completes Kiadis acquisition	21-04-19	AQ
Sanofi : Closes $368 Million Purchase of Kiadis	21-04-18	MT
Kiadis Pharma N : Minutes of the EGM held on 30 March 2021	21-04-14	PU
Kiadis Pharma N.V.(ENXTAM:KDS) dropped from Netherlands ASCX AMS Small Cap Index	21-04-14	CI
Sanofi : Declares Kiadis Offer Unconditional, All Offer Conditions Now Satisfied	21-04-13	MT
Sanofi : Declares Offer for Immunotherapy Company Kiadis Unconditional	21-04-13	MT
Sanofi Foreign Participations B.V. completed the acquisition of Kiadis Pharma N.V. from Life Sciences Partners BV and others.	21-04-11	CI
Kiadis Pharma N : Sanofi's Takeover Offer for Kiadis Receives Commitments from 49% Shareholders	21-04-09	MT
Kiadis Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-07	CI
Kiadis Pharma N.V. Auditor Raises 'Going Concern' Doubt	21-04-06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Kiadis Pharma N.V.

Equities

KDS

NL0011323407

Summary

Filters